PCR technologies market to grow to $21.89b by 2030

The Asia-Pacific region will witness the highest growth.

The PCR technologies market is expected to grow to $21.89b by 2030, at a compound annual growth rate of 7%, according to Markets and Markets. 

The growth is attributed to increasing applications in life sciences, such as genomics, disease detection, and cell analysis, alongside higher public and private investments.

By product segment, the market is segmented into reagents and consumables, which account for the largest share, instruments, and software & services.

In terms of technique, the market is divided into conventional PCR, real-time PCR (qPCR), digital PCR (dPCR), reverse transcription PCR (RT-PCR), hot-start PCR, multiplex PCR, and other PCR techniques. The qPCR segment holds the largest share of the market.

Although high equipment costs are posing challenges for smaller labs, innovations such as real-time PCR, digital PCR, and point-of-care diagnostics are fostering demand. 

The Asia-Pacific region will witness the highest growth due to increased healthcare investments and the expansion of precision medicine.